Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.6310
+0.0270 (4.47%)
At close: Jun 22, 2026, 4:00 PM EDT
0.6310
0.00 (0.00%)
After-hours: Jun 22, 2026, 8:00 PM EDT
MTNB Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
4.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.10M | -2.09M | -65.62% |
| Dec 31, 2022 | 3.19M | 3.16M | 9,560.61% |
| Dec 31, 2021 | 33.00K | -125.33K | -79.16% |
| Dec 31, 2020 | 158.33K | 68.52K | 76.29% |
| Dec 31, 2019 | 89.81K | -29.94K | -25.00% |
| Dec 31, 2018 | 119.75K | -29.94K | -20.00% |
| Dec 31, 2017 | 149.69K | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 194.49K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bio Green Med Solution | 1.53M |
| 60 Degrees Pharmaceuticals | 1.31M |
| SciSparc | 856.00K |
| GeoVax Labs | 852.28K |
| Onconetix | 735.20K |
| Virax Biolabs Group | 2.99K |
MTNB News
- 6 days ago - Matinas BioPharma files $150M mixed securities shelf - TheFly
- 6 days ago - Matinas BioPharma Holdings Registration statement: Registration filing - Filings
- 6 weeks ago - Matinas BioPharma Holdings Quarterly report: Q1 2026 - Filings
- 2 months ago - Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewsWire
- 2 months ago - Matinas BioPharma Holdings Annual report: Q4 2025 - Filings
- 8 months ago - Matinas BioPharma Holdings Quarterly report: Q3 2025 - Filings
- 11 months ago - Matinas BioPharma Holdings Quarterly report: Q2 2025 - Filings
- 1 year ago - Matinas BioPharma Holdings Quarterly report: Q1 2025 - Filings